Poorly differentiated carcinoma of the lung presenting with Lambert - Eaton myasthenic syndrome

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 1, 2000, Pages 58-59

  Nair, Sreejith G ^a   Kumar, B Santhosh ^b   Rajan, Balakrishnan ^a  

^a REGIONAL CANCER CENTRE   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Carcinoma; LEMS; Lung

Indexed keywords

CISPLATIN; CORTICOSTEROID; ETOPOSIDE; IFOSFAMIDE; PYRIDOSTIGMINE;

ADULT; ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0034123339     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200002000-00016     Document Type: Article

References (7)

1. John WJ, Foon KA, Patchell RA. Paraneoplastic syndromes. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997: 46:2397-422.
2. Dropcho EJ. Neurological paraneoplastic syndromes. J Neurol Sci 1998;53:264-78.
3. Lambert E, Rook E. Myasthenic state and lung cancer. In: Brain L, Norris FJ, eds. The remote effects of cancer on the nervous system. New York: Grune and Stratton, 1965:67-80.
4. Oh SJ, Kim DE, Kunoglu R, Brooks J, Claussen S. Electrophysiological and clinical correlation in the Lambert Eaton myasthenia syndrome. Muscle Nerve 1996;19:903-6.
5. Dalman JO, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 1997;24:318-28.
6. Bain PG, Motomura M, Newson-Davies J, et al. Effect of intravenous immunoglobulin on muscle weakness and calcium channel antibodies in the Lambert-Eaton myasthenic syndrome. Neurology 1996:678-83.
7. Chalk CH, Murray NMF, Newson-Davies J, O'Neill JH, Spiro SG. Response of Lambert-Eaton myasthenic syndrome to treatment of associated small cell lung cancer. Neurology 1990;40:1552-6.